<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(12)</volume><submitter>Guinde J</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Appropriate pre-operative staging is a cornerstone in the treatment of non-small cell lung cancer (NSCLC). Central location and size greater than 3 cm are amongst indications for pre-operative invasive mediastinal staging but the quality of the evidence behind this recommendation is low.&lt;h4>Methods&lt;/h4>We retrospectively reviewed all cases of cT2-4N0M0 NSCLCL after CT and TEP-CT which underwent surgical resection with lymph node dissection or had a positive invasive pre-operative mediastinal staging in our institution from 2014 to 2018.&lt;h4>Results&lt;/h4>Three hundred and ten patients met inclusion criteria, 79 (25.5%) central and 231 (74.5%) peripheral tumors. Central tumor location was associated with a higher prevalence of pN2-3 disease (17.7% &lt;i>vs.&lt;/i> 6.1%, P&lt;0.001). </pubmed_abstract><journal>Journal of thoracic disease</journal><pagination>7156-7163</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7797819</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Central location and risk of imaging occult mediastinal lymph node involvement in cN0T2-4 non-small cell lung cancer.</pubmed_title><pmcid>PMC7797819</pmcid><pubmed_authors>Guinde J</pubmed_authors><pubmed_authors>Bourdages-Pageau E</pubmed_authors><pubmed_authors>Ugalde PA</pubmed_authors><pubmed_authors>Fortin M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Central location and risk of imaging occult mediastinal lymph node involvement in cN0T2-4 non-small cell lung cancer.</name><description>&lt;h4>Background&lt;/h4>Appropriate pre-operative staging is a cornerstone in the treatment of non-small cell lung cancer (NSCLC). Central location and size greater than 3 cm are amongst indications for pre-operative invasive mediastinal staging but the quality of the evidence behind this recommendation is low.&lt;h4>Methods&lt;/h4>We retrospectively reviewed all cases of cT2-4N0M0 NSCLCL after CT and TEP-CT which underwent surgical resection with lymph node dissection or had a positive invasive pre-operative mediastinal staging in our institution from 2014 to 2018.&lt;h4>Results&lt;/h4>Three hundred and ten patients met inclusion criteria, 79 (25.5%) central and 231 (74.5%) peripheral tumors. Central tumor location was associated with a higher prevalence of pN2-3 disease (17.7% &lt;i>vs.&lt;/i> 6.1%, P&lt;0.001). </description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Dec</publication><modification>2025-04-04T19:53:47.912Z</modification><creation>2025-04-04T19:53:47.912Z</creation></dates><accession>S-EPMC7797819</accession><cross_references><pubmed>33447404</pubmed><doi>10.21037/jtd-20-1565</doi></cross_references></HashMap>